PGI2 PREDICTORS OF PROTON PUMP INHIBITOR (PPI) DOSING REGIMEN AMONG PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD)
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.999
https://www.valueinhealthjournal.com/article/S1098-3015(11)01138-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
478
First Page :
A180
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01138-7&doi=10.1016/j.jval.2011.02.999